Company profile for Sotio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SOTIO is an international biotechnology company leading the efforts of PPF Group, one of the largest investment groups in Central and Eastern Europe, to build a diverse pharma company specializing in oncology. SOTIO pursues this goal through its the SOTIO® in-house research and clinical development and related services, collaborations with external partners, in-licensing deals, investments and acquisitions. The company is dev...
SOTIO is an international biotechnology company leading the efforts of PPF Group, one of the largest investment groups in Central and Eastern Europe, to build a diverse pharma company specializing in oncology. SOTIO pursues this goal through its the SOTIO® in-house research and clinical development and related services, collaborations with external partners, in-licensing deals, investments and acquisitions. The company is developing new therapies focusing on the treatment of cancer and autoimmune diseases. SOTIO has established the key capabilities required for research, preclinical and clinical development, commercial planning.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Czech Republic
Address
Address
Jankovcova 1518/2 170 00 Prague 7, 24662623
Telephone
Telephone
+420 224 175 111
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251112176967/en/SOTIO-Presents-Positive-Results-from-Non-Human-Primate-Study-of-SOT106-a-Potential-Best-in-Class-ADC-for-Treatment-of-Sarcoma

BUSINESSWIRE
12 Nov 2025

https://www.businesswire.com/news/home/20251103828716/en/SOTIO-Announces-Promotion-of-Vivi-Boura-to-Chief-Medical-Officer

BUSINESSWIRE
03 Nov 2025

https://www.businesswire.com/news/home/20251030199218/en/SOTIO-to-Present-Data-Highlighting-Progress-Across-ADC-and-Immunocytokine-Programs-at-Upcoming-Scientific-Conferences

BUSINESSWIRE
30 Oct 2025

https://www.businesswire.com/news/home/20251002566770/en/SOTIO-Strengthens-Leadership-Team-with-Appointments-of-Amy-Jensen-Smith-as-Chief-Scientific-Officer-and-Ulrich-Moebius-as-Chief-Development-Officer

BUSINESSWIRE
02 Oct 2025

https://www.businesswire.com/news/home/20250429094967/en/SOTIO-Reports-Promising-Preclinical-Data-on-Antibody-Drug-Conjugates-SOT109-and-SOT106-Underscoring-Best-in-Class-Potential-for-Solid-Tumor-Treatments

BUSINESSWIRE
29 Apr 2025

https://www.businesswire.com/news/home/20250325193238/en/SOTIO-to-Present-Preclinical-Data-on-Lead-Antibody-Drug-Conjugates-SOT106-and-SOT109-at-2025-AACR-Annual-Meeting

BUSINESSWIRE
26 Mar 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty